Anja E Schiel

Anja Schiel has studied Biology at the Johannes Gutenberg-University, Mainz, Germany. She received her PhD from the Free University in Amsterdam in 2006 and worked several years as Post-Doc on a range of subjects focusing on oncology, immunology and molecular biology, first at the University of Leiden and later at the University of Oslo, before starting at the Nor-wegian Medical Products Agency (NOMA) in 2012. At NOMA she is working as Special Adviser/Statistician/Methodologist both on regulatory and HTA projects. She has been Chair of EMA’s Biostatistics Working Party (2017 – 2019) and dur-ing 2019 – 2022 she was Chair of EMA’s Scientific Advice Working Party (SAWP). She contin-ues currently as alternate member at the SAWP and is member of the recently established Methodology Working Party (MWP) at EMA. She has been involved in EUnetHTA JA3 and its successor, EUnetHTA 21, with particular focus on parallel EMA-HTA scientific advice (joined scientific consultations). As one of the vice